血液悪性腫瘍の世界市場：市場規模・現状・予測

• 英文タイトル：Global Hematological Malignancies Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04867
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、血液悪性腫瘍の世界市場について調査・分析し、血液悪性腫瘍の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（白血病、リンパ腫、骨髄腫）、用途別（病院薬局、医療店、Eコマースプラットフォーム）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の血液悪性腫瘍市場動向
・主要企業別マーケットシェア
・血液悪性腫瘍の種類別市場規模2014-2019
（白血病、リンパ腫、骨髄腫）
・血液悪性腫瘍の用途別市場規模2014-2019
（病院薬局、医療店、Eコマースプラットフォーム）
・血液悪性腫瘍の北米市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍のヨーロッパ市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍の中国市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍の日本国内市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍の東南アジア市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍のインド市場：主要企業・種類別/用途別市場規模
・血液悪性腫瘍の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（AbbVie、Bristol-Myers Squibb、Celgene、Roche、GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Teva Pharmaceutical）
・血液悪性腫瘍の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.In 2018, the global Hematological Malignancies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hematological Malignancies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematological Malignancies development in United States, Europe and China.

The key players covered in this study
AbbVie
Bristol-Myers Squibb
Celgene
Roche
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Teva Pharmaceutical

Market segment by Type, the product can be split into
Leukemia
Lymphoma
Myeloma

Market segment by Application, split into
Hospital Pharmacies
Medical Stores
E-commerce Platform

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hematological Malignancies status, future forecast, growth opportunity, key market and key players.
To present the Hematological Malignancies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hematological Malignancies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hematological Malignancies Market Size Growth Rate by Type (2014-2025)
1.4.2 Leukemia
1.4.3 Lymphoma
1.4.4 Myeloma
1.5 Market by Application
1.5.1 Global Hematological Malignancies Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Medical Stores
1.5.4 E-commerce Platform
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hematological Malignancies Market Size
2.2 Hematological Malignancies Growth Trends by Regions
2.2.1 Hematological Malignancies Market Size by Regions (2014-2025)
2.2.2 Hematological Malignancies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hematological Malignancies Market Size by Manufacturers
3.1.1 Global Hematological Malignancies Revenue by Manufacturers (2014-2019)
3.1.2 Global Hematological Malignancies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hematological Malignancies Market Concentration Ratio (CR5 and HHI)
3.2 Hematological Malignancies Key Players Head office and Area Served
3.3 Key Players Hematological Malignancies Product/Solution/Service
3.4 Date of Enter into Hematological Malignancies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hematological Malignancies Market Size by Type (2014-2019)
4.2 Global Hematological Malignancies Market Size by Application (2014-2019)

5 United States
5.1 United States Hematological Malignancies Market Size (2014-2019)
5.2 Hematological Malignancies Key Players in United States
5.3 United States Hematological Malignancies Market Size by Type
5.4 United States Hematological Malignancies Market Size by Application

6 Europe
6.1 Europe Hematological Malignancies Market Size (2014-2019)
6.2 Hematological Malignancies Key Players in Europe
6.3 Europe Hematological Malignancies Market Size by Type
6.4 Europe Hematological Malignancies Market Size by Application

7 China
7.1 China Hematological Malignancies Market Size (2014-2019)
7.2 Hematological Malignancies Key Players in China
7.3 China Hematological Malignancies Market Size by Type
7.4 China Hematological Malignancies Market Size by Application

8 Japan
8.1 Japan Hematological Malignancies Market Size (2014-2019)
8.2 Hematological Malignancies Key Players in Japan
8.3 Japan Hematological Malignancies Market Size by Type
8.4 Japan Hematological Malignancies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hematological Malignancies Market Size (2014-2019)
9.2 Hematological Malignancies Key Players in Southeast Asia
9.3 Southeast Asia Hematological Malignancies Market Size by Type
9.4 Southeast Asia Hematological Malignancies Market Size by Application

10 India
10.1 India Hematological Malignancies Market Size (2014-2019)
10.2 Hematological Malignancies Key Players in India
10.3 India Hematological Malignancies Market Size by Type
10.4 India Hematological Malignancies Market Size by Application

11 Central & South America
11.1 Central & South America Hematological Malignancies Market Size (2014-2019)
11.2 Hematological Malignancies Key Players in Central & South America
11.3 Central & South America Hematological Malignancies Market Size by Type
11.4 Central & South America Hematological Malignancies Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hematological Malignancies Introduction
12.1.4 AbbVie Revenue in Hematological Malignancies Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hematological Malignancies Introduction
12.2.4 Bristol-Myers Squibb Revenue in Hematological Malignancies Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hematological Malignancies Introduction
12.3.4 Celgene Revenue in Hematological Malignancies Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hematological Malignancies Introduction
12.4.4 Roche Revenue in Hematological Malignancies Business (2014-2019)
12.4.5 Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hematological Malignancies Introduction
12.5.4 GlaxoSmithKline Revenue in Hematological Malignancies Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hematological Malignancies Introduction
12.6.4 Johnson & Johnson Revenue in Hematological Malignancies Business (2014-2019)
12.6.5 Johnson & Johnson Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hematological Malignancies Introduction
12.7.4 Novartis Revenue in Hematological Malignancies Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hematological Malignancies Introduction
12.8.4 Pfizer Revenue in Hematological Malignancies Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hematological Malignancies Introduction
12.9.4 Teva Pharmaceutical Revenue in Hematological Malignancies Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hematological Malignancies Key Market Segments
Table Key Players Hematological Malignancies Covered
Table Global Hematological Malignancies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hematological Malignancies Market Size Market Share by Type 2014-2025
Figure Leukemia Figures
Table Key Players of Leukemia
Figure Lymphoma Figures
Table Key Players of Lymphoma
Figure Myeloma Figures
Table Key Players of Myeloma
Table Global Hematological Malignancies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Medical Stores Case Studies
Figure E-commerce Platform Case Studies
Figure Hematological Malignancies Report Years Considered
Table Global Hematological Malignancies Market Size 2014-2025 (Million US$)
Figure Global Hematological Malignancies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hematological Malignancies Market Size by Regions 2014-2025 (Million US$)
Table Global Hematological Malignancies Market Size by Regions 2014-2019 (Million US$)
Table Global Hematological Malignancies Market Share by Regions 2014-2019
Figure Global Hematological Malignancies Market Share by Regions 2014-2019
Figure Global Hematological Malignancies Market Share by Regions 2019
Table Market Top Trends
Table Global Hematological Malignancies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hematological Malignancies Market Share by Manufacturers (2014-2019)
Figure Global Hematological Malignancies Market Share by Manufacturers in 2018
Table Global Hematological Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hematological Malignancies Product/Solution/Service
Table Date of Enter into Hematological Malignancies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table Global Hematological Malignancies Market Size Share by Type (2014-2019)
Figure Global Hematological Malignancies Market Size Market Share by Type (2014-2019)
Table Global Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table Global Hematological Malignancies Market Size Share by Application (2014-2019)
Figure Global Hematological Malignancies Market Size Market Share by Application (2014-2019)
Figure Global Hematological Malignancies Revenue Market Share by Application in 2018
Figure United States Hematological Malignancies Market Size 2014-2019 (Million US$)
Table United States Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table United States Key Players Hematological Malignancies Market Share (2018-2019)
Table United States Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table United States Hematological Malignancies Market Share by Type (2014-2019)
Table United States Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table United States Hematological Malignancies Market Share by Application (2014-2019)
Figure Europe Hematological Malignancies Market Size 2014-2019 (Million US$)
Table Europe Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table Europe Key Players Hematological Malignancies Market Share (2018-2019)
Table Europe Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table Europe Hematological Malignancies Market Share by Type (2014-2019)
Table Europe Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table Europe Hematological Malignancies Market Share by Application (2014-2019)
Figure China Hematological Malignancies Market Size 2014-2019 (Million US$)
Table China Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table China Key Players Hematological Malignancies Market Share (2018-2019)
Table China Hematological Malignancies Market Size by Type (2014-20189) (Million US$)
Table China Hematological Malignancies Market Share by Type (2014-2019)
Table China Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table China Hematological Malignancies Market Share by Application (2014-2019)
Figure Japan Hematological Malignancies Market Size 2014-2019 (Million US$)
Table Japan Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table Japan Key Players Hematological Malignancies Market Share (2018-2019)
Table Japan Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table Japan Hematological Malignancies Market Share by Type (2014-2019)
Table Japan Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table Japan Hematological Malignancies Market Share by Application (2014-2019)
Figure Southeast Asia Hematological Malignancies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hematological Malignancies Market Share (2018-2019)
Table Southeast Asia Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hematological Malignancies Market Share by Type (2014-2019)
Table Southeast Asia Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hematological Malignancies Market Share by Application (2014-2019)
Figure India Hematological Malignancies Market Size 2014-2019 (Million US$)
Table India Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table India Key Players Hematological Malignancies Market Share (2018-2019)
Table India Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table India Hematological Malignancies Market Share by Type (2014-2019)
Table India Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table India Hematological Malignancies Market Share by Application (2014-2019)
Figure Central & South America Hematological Malignancies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hematological Malignancies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hematological Malignancies Market Share (2018-2019)
Table Central & South America Hematological Malignancies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hematological Malignancies Market Share by Type (2014-2019)
Table Central & South America Hematological Malignancies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hematological Malignancies Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in Hematological Malignancies Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table AbbVie Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Celgene Recent Development
Table Roche Company Details
Table Roche Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Pfizer Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Hematological Malignancies Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Hematological Malignancies Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Global Hematological Malignancies Market Size by Regions (Million US$) 2019-2025
Figure Global Hematological Malignancies Market Size Share by Regions (2019-2025)
Figure Global Hematological Malignancies Market Size Share by Regions in 2025
Figure United States Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure China Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure India Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hematological Malignancies Market Size Forecast (2019-2025)(Million USD)
Table Global Hematological Malignancies Market Size by Product (2019-2025) (Million US$)
Figure Global Hematological Malignancies Market Size by Product (2019-2025)
Figure Global Hematological Malignancies Market Size by Product in 2025
Table Global Hematological Malignancies Market Size by Application (2019-2025) (Million US$)
Figure Global Hematological Malignancies Market Size by Application (2019-2025)
Figure Global Hematological Malignancies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

非血液癌の世界市場：市場規模・現状・予測

Global Non-Hematological Cancers Market Size, Status and Forecast 2019-2025
QYR9ST03957 2019年9月2日 98Pages
※当調査レポートでは、非血液癌の世界市場について調査・分析し、非血液癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、手術、放射線療法、その他）、用途別（病院、腫瘍治療センター、外来手術セ...

血液疾患用薬物および診断の世界市場：市場規模・現状・予測

Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025
QYR9ST03871 2019年9月2日 98Pages
※当調査レポートでは、血液疾患用薬物および診断の世界市場について調査・分析し、血液疾患用薬物および診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（分析装置、試薬）、用途別（学術研究所、ポイントオ...

血液疾患診断及び治療の世界市場：市場規模・現状・予測

Global Hematological Disorders Diagnostic and Therapeutic Market Size, Status and Forecast 2019-2025
QYR9ST03906 2019年9月2日 95Pages
※当調査レポートでは、血液疾患診断及び治療の世界市場について調査・分析し、血液疾患診断及び治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物、物理）、用途別（病院、診療所）、地域別（北米、ヨー...

バイオテクノロジーの世界市場：市場規模・現状・予測

Global Biotechnology Market Size, Status and Forecast 2019-2025
QYR9ST05244 2019年9月2日 92Pages
※当調査レポートでは、バイオテクノロジーの世界市場について調査・分析し、バイオテクノロジーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（DNAシーケンス、ナノバイオテクノロジー、組織工学および再生...

創薬の世界市場：市場規模・現状・予測

Global Drug Discovery Market Size, Status and Forecast 2019-2025
QYR9ST04813 2019年9月2日 90Pages
※当調査レポートでは、創薬の世界市場について調査・分析し、創薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（小分子薬、生物製剤）、用途別（研究所、製薬会社、バイオテクノロジー会社）、地域別（北米、...

鳥インフルエンザ治療の世界市場：市場規模・現状・予測

Global Avian Flu Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04109 2019年9月2日 96Pages
※当調査レポートでは、鳥インフルエンザ治療の世界市場について調査・分析し、鳥インフルエンザ治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗生物質、ワクチン、抗ウイルス剤、免疫グロブリン）、用途...

ドナー卵IVF治療の世界市場：市場規模・現状・予測

Global Donor Egg IVF Treatment Market Size, Status and Forecast 2019-2025
QYR9ST00301 2019年9月2日 94Pages
※当調査レポートでは、ドナー卵IVF治療の世界市場について調査・分析し、ドナー卵IVF治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（新鮮なドナー卵IVFサイクル、冷凍ドナー卵IVFサイクル）、...

心電図の世界市場：市場規模・現状・予測

Global Telecardiology Market Size, Status and Forecast 2019-2025
QYR9ST03725 2019年9月2日 98Pages
※当調査レポートでは、心電図の世界市場について調査・分析し、心電図の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ITサービス、テレコム、ソフトウェア、ハードウェア）、用途別（診断、ヘルスモニタリン...

ヘルスケアラボインフォマティクスの世界市場：市場規模・現状・予測

Global Healthcare Lab Informatics Market Size, Status and Forecast 2019-2025
QYR9ST02733 2019年9月2日 107Pages
※当調査レポートでは、ヘルスケアラボインフォマティクスの世界市場について調査・分析し、ヘルスケアラボインフォマティクスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ラボ情報管理システム（LIMS）...

寄生虫性疾患の世界市場：市場規模・現状・予測

Global Parasitic Diseases Therapeutic Market Size, Status and Forecast 2019-2025
QYR9ST07324 2019年9月5日 90Pages
※当調査レポートでは、寄生虫性疾患の世界市場について調査・分析し、寄生虫性疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ペプチド医学、防虫剤、殺ダニ剤、その他）、用途別（商業用、家庭用）、地域...

非血液癌の世界市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…
血液疾患診断及び治療の世界市場：市場規模・現状・予測 Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…
血液疾患用薬物および診断の世界市場：市場規模・現状・予測 Hematological disorders deal with blood related diseases and generally affect the quantity or functionality of the cells or proteins present in the blood.Some blood disorders result in the increase of the number of cells in blood such as anemia, leukopenia while other cause the number of blood cells…
デジタルコマースプラットフォームの世界市場：市場規模・現状・予測 The digital commerce platform find a massive scope of growth due to the evolving cloud computing services that are making it easier and faster for consumers to avail digital content. In 2018, the global Digital Commerce Platform market size was xx million US$ and it is expected to reach xx million U…
多発性骨髄腫診断の世界市場：市場規模・現状・予測 Plasma cells help in fighting infection however, malignant plasma cells in multiple myeloma accumulate in the bone marrow, blocks the normal function of plasma cells. The M protein which is an abnormal antibody produced by malignant plasma cells cause tumors, bone destruction, kidney damage, and dam…